Serotype Distribution and Antibiotic Susceptibilities of Clinical Streptococcus pneumoniae Strains
Serotype Distribution and Antibiotic Susceptibilities of Clinical Streptococcus pneumoniae Strains
Purpose: Streptococcus pneumoniae is a pathogen that cause significant mortality and morbidity in humans. In particular, bacteremia,pneumonia, meningitis and middle ear inflammation. S.pneumoniae can cause many diseases in children and adults. Recently, S.pneumoniaeis the most important cause of acute respiratory tract diseases in developing countries. Increasing antibiotic resistance in S.pneumoniae strainshas recently gained importance. The aim of our study was to investigate the antimicrobial susceptibility and distribution of pneumococcalserotypes of S.pneumoniae strains isolated in our University Hospital.Methods: In this study we evaluated 80 S.pneumoniae strains isolated from adults and children between September 2012 and September 2013.The isolates were obtained from sputum (n=56), nasal secretions (n=4), throat swabs (n=1), blood (n=9), tracheal aspirat (n=2), conjunctivalsmear (n=1), bronchoalveolar lavage (n=6), and biopsy (n=1). Seventy-six isolates were from adults and four were from children. Antibioticsusceptibility testing to penicillin were performed on Mueller-Hinton agar supplemented with 5% sheep blood by the E-test method(bioMerieux, France); erythromycin, clindamycin, vancomycin, chloramphenicol, tetracycline, ofloxacine, levofloxacin, trimethoprim/sulfamethoxazole, rifampin, linezolid, and oxacillin susceptibilities performed by disc diffusion method and 7-10-13-valent Pneumotest-Latex(Statens Serum Institude, Denmark) kit was used for serotyping.Results: A total of 39/80 isolates (48.75%) were intermediate, and 5/80 (6.25%) were resistant to penicillin according to Clinical & LaboratoryStandards Institude (CLSI) guidelines for oral penicillin. Penicillin resistance was not found for parenteral penicillin. Resistance rates oferythromycin, clindamycin, vancomycin, chloramphenicol, tetracycline, ofloxacine, levofloxacin, trimethoprim/sulfamethoxazole, rifampin,and linezolid were as 31.25%, 21.25%, 0%, 5%, 28.75%, 15%, 2.5%, 45%, 0%, and 0% respectively. The most common S.pneumoniae serotypeswere determined as serotypes 19, 6, and 23. Serotyping showed serotype 19 to be the leading serotype among the macrolide-resistant isolates,and serotype coverage of 7-10-13-valent pneumococcal vaccine was 68.75%.Conclusion: The increase in intermediate penicillin resistance in S.pneumoniae in our hospital should be monitored carefully and thedistribution of pneumococcal serotypes is similar to countries where the Pneumococcal Conjugate Vaccine (PCV) has been introduced.
___
- Cherian T. WHO expert consultation on serotype composition
of pneumococcal conjugate vaccines for use in resource-poor
developing countries, 26–27 October 2006, Geneva. Vaccine
2007;25:6557–6564. [CrossRef]
- Reinert RR. The antimicrobial resistance profile of Streptococcus
pneumoniae. Clin Microbiol Infect 2009;15 Suppl 3:7–11. [CrossRef]
- Van Eldere J, Mera RM, Miller LA, Poupard JA, Amrine-Madsen
H. Risk factors for development of multiple-class resistance to
Streptococcus pneumoniae strains in Belgium over a 10-year period:
Antimicrobial consumption, population density, and geographic
location. Antimicrob Agents Chemother 2007;51:3491–97. [CrossRef]
- Richter SS, Heilmann KP, Dohrn CL, Riahi F, Beekmann SE, Doern GV.
Changing epidemiology of antimicrobial-resistant Streptococcus
pneumoniae in the United States, 2004–2005. Clin Infect Dis
2009;1:48:e23–33. [CrossRef]
- Kim SH, Song JH, Chung DR, et al. Changing trends in antimicrobial
resistance and serotypes of Streptococcus pneumoniae isolates
in Asian countries: an Asian Network for Surveillance of Resistant
Pathogens (ANSORP) study. Antimicrob Agents Chemother
2012;56:1418–1426. [CrossRef]
- Altinkanat Gelmez G, Soysal A, Kuzdan C, et al. Serotype Distribution
and antibiotic susceptibilities of Streptococcus pneumonia causing
acute exacerbations and pneumonia in children with chronic
respiratory diseases. Mikrobiyol Bul 2013;47(4):684–692.
- Gonullu N, Catal F, Kucukbasmaci O, Ozdemir S, Torun MM,
Berkiten R. Comparison of in vitro activities of tigecycline with
other antimicrobial agents against Streptococcus pneumoniae,
Haemophilus influenzae and Moraxella catarrhalis in two university
hospitals in Istanbul, Turkey. Chemotherapy 2009;55:161–167.
[CrossRef]
- Hsueh PR, Teng LJ, Lee LN, Yang PC, Ho SW, Luh KT. Extremely
high incidence of macrolide and trimethoprim-sulfamethoxazole
resistance among clinical isolates of Streptococcus pneumoniae in
Taiwan. J ClinMicrobiol 1999;37:897–901.
- Sessegolo JF, Levin AS, Levy CE, Asensi M, Facklam RR, Teixeira
LM. Distribution of serotypes and antimicrobial resistance of
Streptococcus pneumoniae strains isolated in Brazil from 1988 to
1992. J Clin Microbiol 1994;32:906–911.
- Ozalp M, Kanra G, Gür D. Distribution of serotypes and antimicrobial
resistance of Streptococcus pneumoniae in a children’s hospital in
Turkey. Turk J Pediatr 2004;46:329–332.
- Centers for Disease Control and Prevention (CDC). Emergence of
antimicrobial-resistant serotype 19A Streptococcus pneumoniae
- Massachusetts, 2001–2006. MMWR Morb Mortal Wkly Rep
2007;56:1077–1080.
- Soysal A, Karabağ-Yılmaz E, Kepenekli E, et al. The impact
of a pneumococcal conjugate vaccination program on the
nasopharyngeal carriage, serotype distribution and antimicrobial
resistance of Streptococcus pneumoniae among healthy children in
Turkey. Vaccine 2016:34 33:3894–3900. [CrossRef]
- Arvas A, Çokuğraş E, Gür E, Gönüllü N, Taner Z, Tokman HB.
Pneumococcal Nasopharyngeal Carriage in Young Healthy Children
After Pneumococcal Conjugate Vaccine in Turkey. Balkan Med J
2017:34:362–366. [CrossRef]